The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 4 Correlation between MDS-UPDRS* and MMSE and WAIS-R*

From: Study of cognitive impairment and genetic polymorphism of SLC41A1 (rs11240569 allele) in Parkinson’s disease in Upper Egypt: case-control study

	MMSE		WAIS total		WAIS verbal		WAIS Performance
	R	P value	R	P value	r	P value	R	P value
MDS-UPDRS Part I	− .585	.000	− .439	.002	− .552	.000	− .312	.031
MDS-UPDRS Part II	− .340	.017	− .180	.220	− .268	.066	− .140	.341
MDS-UPDRS Part III	− .392	.006	− .173	.240	− .354	.013	− .095	.522
MDS-UPDRS Part IV	− .371	.009	− .116	.433	− .365	.011	− .037	.803

*MDS-UPDRS Movement Disorder Society-Unified Parkinson Disease rating Scale
**MMSE Mini-mental state examination
***WAIS-R Wechsler Adult Intelligence Scale–Revised

Back to article page